Safety and antigenicity of typhoid-Shigella sonnei vaccine (strain 5076-1C)

J Infect Dis. 1984 Feb;149(2):133-6. doi: 10.1093/infdis/149.2.133.

Abstract

The form-1 antigen of Shigella sonnei was transferred to the avirulent Salmonella typhi strain 21a and the resulting 5076-1C transconjugate strain was tested for safety and immunogenicity as a candidate oral vaccine. The transconjugant strain was shown to be well tolerated and safe in 19 human volunteers who were fed from 1 X 10(7) to 1 X 10(10) organisms. Only two of 10 volunteers tested had developed a rise in antibody titer to the lipopolysaccharide of the hybrid 5076-1C strain.

MeSH terms

  • Administration, Oral
  • Animals
  • Antibodies, Bacterial / analysis
  • Antigens, Bacterial / immunology*
  • Bacterial Vaccines / immunology*
  • Bacterial Vaccines / standards
  • Conjugation, Genetic
  • Dysentery, Bacillary / prevention & control
  • Feces / microbiology
  • Female
  • Guinea Pigs
  • Humans
  • Lipopolysaccharides / immunology
  • Male
  • Plasmids
  • Salmonella typhi / genetics
  • Salmonella typhi / immunology*
  • Shigella sonnei / genetics
  • Shigella sonnei / immunology*
  • Typhoid Fever / prevention & control
  • Typhoid-Paratyphoid Vaccines / immunology*
  • Typhoid-Paratyphoid Vaccines / standards

Substances

  • Antibodies, Bacterial
  • Antigens, Bacterial
  • Bacterial Vaccines
  • Lipopolysaccharides
  • Typhoid-Paratyphoid Vaccines